𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trial on 5-AZA-2′-deoxycytidine in patients with acute leukemia

✍ Scribed by Richard L. Momparler; Georges E. Rivard; Martin Gyger

Book ID
118385385
Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
749 KB
Volume
30
Category
Article
ISSN
0163-7258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study on 5-aza-2′-deoxycytidine
Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia
✍ Georges E. Rivard; Richard L. Momparler; Jocelyn Demers; Paul Benoit; Richard Ra 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 709 KB

Ahstract--A Phase I study with 5-aza-2'-deoxycytidine (5-AZA-CdR) was performed on children with acute leukemia who were resistant to conventional chemotherapy. The objective of this study was to find the dose-schedule of 5-AZA-CdR that produced a potent antileukemic effect and to evaluate its toxic

Results of decitabine (5-aza-2′deoxycyti
Results of decitabine (5-aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia
✍ Hagop M. Kantarjian; Susan O'Brien; Jorge Cortes; Francis J. Giles; Stefan Fader 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## BACKGROUND General and site‐specific DNA methylation is associated with tumor progression and resistance in several cancers, including chronic myelogenous leukemia (CML). Decitabine is a hypomethylating agent that has shown encouraging preliminary anti‐CML activity. This study evalu